31 – 40 of 615
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
3D cultivation of non-small-cell lung cancer cell lines using four different methods
- Contribution to journal › Article
-
Mark
Reprogramming Stars #18 : Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall
- Contribution to journal › Letter
-
Mark
HMGA1 stimulates cancer stem-like features and sensitivity to monensin in gastric cancer
- Contribution to journal › Article
-
Mark
Reprogramming Stars #15 : Colliding Cellular Reprogramming Paths— An Interview with Dr. Stefan Stricker
- Contribution to journal › Debate/Note/Editorial
-
Mark
Of gains and losses : SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome
- Contribution to journal › Scientific review
-
Mark
In-depth proteomic analysis and structural modelling of protein-protein interactions identify known and novel molecular binding partners for EMP3 in erythroid cells
- Contribution to journal › Published meeting abstract
-
Mark
The Impact of Senescent Cells on Limb Regeneration
- Contribution to journal › Debate/Note/Editorial
-
Mark
Osteopontin : A Key Multifaceted Regulator in Tumor Progression and Immunomodulation
- Contribution to journal › Scientific review
-
Mark
New sickle cell disease drug approved for use in England – here’s how voxelotor works
(2024) In The Conversation
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses
- Contribution to journal › Article
